1P94
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 1p94 by Molmil](/molmil-images/mine/1p94) | NMR Structure of ParG symmetric dimer | 分子名称: | plasmid partition protein ParG | 著者 | Golovanov, A.P, Barilla, D, Golovanova, M, Hayes, F, Lian, L.Y. | 登録日 | 2003-05-09 | 公開日 | 2004-01-13 | 最終更新日 | 2024-05-22 | 実験手法 | SOLUTION NMR | 主引用文献 | ParG, a protein required for active partition of bacterial plasmids, has a dimeric ribbon-helix-helix structure. Mol.Microbiol., 50, 2003
|
|
2XKX
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 2xkx by Molmil](/molmil-images/mine/2xkx) | Single particle analysis of PSD-95 in negative stain | 分子名称: | DISKS LARGE HOMOLOG 4 | 著者 | Fomina, S, Howard, T.D, Sleator, O.K, Golovanova, M, O'Ryan, L, Leyland, M.L, Grossmann, J.G, Collins, R.F, Prince, S.M. | 登録日 | 2010-07-15 | 公開日 | 2011-07-20 | 最終更新日 | 2024-05-08 | 実験手法 | ELECTRON MICROSCOPY (22.9 Å), SOLUTION SCATTERING | 主引用文献 | Self-Directed Assembly and Clustering of the Cytoplasmic Domains of Inwardly Rectifying Kir2.1 Potassium Channels on Association with Psd-95 Biochim.Biophys.Acta, 1808, 2011
|
|
2XKY
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 2xky by Molmil](/molmil-images/mine/2xky) | Single particle analysis of Kir2.1NC_4 in negative stain | 分子名称: | INWARD RECTIFIER POTASSIUM CHANNEL 2 | 著者 | Fomina, S, Howard, T.D, Sleator, O.K, Golovanova, M, O'Ryan, L, Leyland, M.L, Grossmann, J.G, Collins, R.F, Prince, S.M. | 登録日 | 2010-07-15 | 公開日 | 2011-07-20 | 最終更新日 | 2024-05-08 | 実験手法 | ELECTRON MICROSCOPY (17.200001 Å), SOLUTION SCATTERING | 主引用文献 | Self-Directed Assembly and Clustering of the Cytoplasmic Domains of Inwardly Rectifying Kir2.1 Potassium Channels on Association with Psd-95 Biochim.Biophys.Acta, 1808, 2011
|
|
6H1L
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 6h1l by Molmil](/molmil-images/mine/6h1l) | Structure of the BM3 heme domain in complex with tioconazole | 分子名称: | 1,2-ETHANEDIOL, 1,4-DIETHYLENE DIOXIDE, Bifunctional cytochrome P450/NADPH--P450 reductase, ... | 著者 | Jeffreys, L.N, Munro, A.W.M, Leys, D. | 登録日 | 2018-07-12 | 公開日 | 2019-02-20 | 最終更新日 | 2024-01-17 | 実験手法 | X-RAY DIFFRACTION (1.968 Å) | 主引用文献 | Novel insights into P450 BM3 interactions with FDA-approved antifungal azole drugs. Sci Rep, 9, 2019
|
|
6H1O
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 6h1o by Molmil](/molmil-images/mine/6h1o) | Structure of the BM3 heme domain in complex with voriconazole | 分子名称: | 1,2-ETHANEDIOL, Bifunctional cytochrome P450/NADPH--P450 reductase, GLYCEROL, ... | 著者 | Jeffreys, L.N, Munro, A.W.M, Leys, D. | 登録日 | 2018-07-12 | 公開日 | 2019-02-20 | 最終更新日 | 2024-01-17 | 実験手法 | X-RAY DIFFRACTION (1.734 Å) | 主引用文献 | Novel insights into P450 BM3 interactions with FDA-approved antifungal azole drugs. Sci Rep, 9, 2019
|
|
6H1T
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 6h1t by Molmil](/molmil-images/mine/6h1t) | Structure of the BM3 heme domain in complex with clotrimazole | 分子名称: | (4S)-2-METHYL-2,4-PENTANEDIOL, 1,2-ETHANEDIOL, 1-[(2-CHLOROPHENYL)(DIPHENYL)METHYL]-1H-IMIDAZOLE, ... | 著者 | Jeffreys, L.N, Munro, A.W.M, Leys, D. | 登録日 | 2018-07-12 | 公開日 | 2019-02-20 | 最終更新日 | 2024-01-17 | 実験手法 | X-RAY DIFFRACTION (2.08 Å) | 主引用文献 | Novel insights into P450 BM3 interactions with FDA-approved antifungal azole drugs. Sci Rep, 9, 2019
|
|
6H1S
![Download](/newweb/media/icons/dl.png) ![Visualize](/newweb/media/icons/hoh_3d.png)
![BU of 6h1s by Molmil](/molmil-images/mine/6h1s) | Structure of the BM3 heme domain in complex with fluconazole | 分子名称: | 1,2-ETHANEDIOL, 2-(2,4-DIFLUOROPHENYL)-1,3-DI(1H-1,2,4-TRIAZOL-1-YL)PROPAN-2-OL, Bifunctional cytochrome P450/NADPH--P450 reductase, ... | 著者 | Jeffreys, L.N, Munro, A.W.M, Leys, D. | 登録日 | 2018-07-12 | 公開日 | 2019-02-20 | 最終更新日 | 2024-01-17 | 実験手法 | X-RAY DIFFRACTION (1.95 Å) | 主引用文献 | Novel insights into P450 BM3 interactions with FDA-approved antifungal azole drugs. Sci Rep, 9, 2019
|
|